Researchers found vaporized nicotine products more effective than nicotine replacement therapy for smoking cessation among socioeconomically disadvantaged adults.
A large clinical trial in Europe showed that a single dose of nirsevimab reduced infant hospitalizations for RSV-associated lower respiratory tract infections by over 80% over a six-month period.
In a small sample, dog acquisition during the COVID-19 pandemic was linked to a brief rise in cheerfulness, followed by potential declines in well-being, with effects varying by caregiving role and measure.
FDA approves Ekterly (sebetralstat), the first oral on-demand treatment for hereditary angioedema, shown in trials to provide faster symptom relief and eliminate the need for injection.
GAMMAGARD LIQUID ERC is the first ready-to-use liquid immunoglobulin therapy with IgA ≤2 µg/mL for primary immunodeficiency in individuals aged 2 years and older.
Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.